Liwen J. Ren
Beijing Key Laboratory Of Innovative Drug Discovery And Polymorphic Druggability Research For Cerebrovascular Diseases, Chinese Academy Of Medical Science And Peking Union Medical College
Beijing, 100050, China
Beijing, 100050, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
IFI30 reprograms glioblastoma-associated macrophage and induces immune evasion by MAFF/PTGS2 pathway.
Journal: Acta pharmaceutica Sinica. B
Published: April 28, 2025
IFI30 promotes tumor-associated macrophage infiltration via activation of the ATF3-CCL5 axis in breast cancer.
Journal: Innovation (Cambridge (Mass.))
Published: February 09, 2025
Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/ FOXO1 pathway.
Journal: Clinical epigenetics
Published: December 28, 2024
Erratum: Author correction to '3-O-Acetyl-11-keto-β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma' [Acta Pharm Sin B 10 (2020) 301-312].
Journal: Acta pharmaceutica Sinica. B
Published: September 02, 2024
Interferon Gamma Inducible Protein 30: from biological functions to potential therapeutic target in cancers.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: July 29, 2024
Correction: MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma.
Journal: Signal transduction and targeted therapy
Published: July 13, 2024
Corrigendum to "Systematic pan-cancer analysis identifies APOC1 as an immunological biomarker which regulates macrophage polarization and promotes tumor metastasis" [Pharmacol. Res. 2022 Sep:183:106376].
Journal: Pharmacological research
Published: June 14, 2024
Corrigendum to "Anti-tumor effects of Skp2 inhibitor AAA-237 on NSCLC by arresting cell cycle at G0/G1 phase and inducing senescence" [Pharmacol. Res. 181 (2022), 106259].
Journal: Pharmacological research
Published: June 14, 2024
Design, synthesis and characterization of a novel multicomponent salt of bexarotene with metformin and application in ameliorating psoriasis with T2DM.
Journal: International journal of pharmaceutics
Published: May 22, 2023
Progress on diagnostic and prognostic markers of pancreatic cancer.
Journal: Oncology research
Published: January 17, 2023
GABAergic signaling as a potential therapeutic target in cancers.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 10, 2023
Recent advances in epigenetic anticancer therapeutics and future perspectives.
Journal: Frontiers in genetics
Published: October 31, 2022
Last Updated: 09/26/2026